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Open access undTumor microenvironment modiﬁcations are related to the generation of reactive stroma and to critical
events in cancer progression, such as proliferation, migration and apoptosis. In order to clarify these cel-
lular interactions mediated by reactive stroma, we investigated the effects of cell–cell contacts, and the
inﬂuence of soluble factors and extracellular matrix (ECM) secreted by Benign Prostate Hyperplasia (BPH)
reactive stroma over LNCaP prostate tumor cells. Using in vitro functional assays, we demonstrated that
ECM strongly stimulated LNCaP cell proliferation and migration, while inhibiting apoptosis, and inducing
a deregulated expression pattern of several genes related to prostate cancer (PCa) progression. Con-
versely, reactive stromal cells per se and their secreted conditioned medium partially modulated these
pro-tumorigenic events. These data indicate that secreted ECM in reactive stroma microenvironment
contains key molecules that positively modulate important cancer hallmarks.
 2012 Elsevier Ireland Ltd. Open access under the Elsevier OA license.1. Introduction
Prostate adenocarcinoma is the sixth most common cancer
worldwide with prevalence among men [1]. In recent years, it
has been demonstrated the importance of tumor microenviron-
ment in many cancer diseases [2,3], and the role of the so-called
reactive stroma has been consolidated itself as a key element in
the progression of prostate cancer (PCa) [4]. Several studies have
shown that reactive stroma is signiﬁcantly different from non-
tumoral stromal compartment [5,6]. The classic works of Olumi
et al. [7,8] provided relevant data about the importance of the stro-
ma in PCa progression, demonstrating that formation of prostate
tumors in xenograft models was only possible in the presence of
stromal cells. Subsequently, it was demonstrated that changes in
tissue homeostasis caused by PCa lead to an increase in prolifera-
tion and invasion of tumor cells, triggering a response from pros-
tatic stroma similar to that observed in the healing process [9].uisa em Biologia Celular e do
niversidade Federal do Rio de
590 Rio de Janeiro, Brazil.
sciutti).
er the Elsevier OA license.Several factors secreted during the healing process are also
released during the formation of reactive stroma in response to tu-
mor growth [10]. These factors include Fibroblast Growth Factor
(FGF-2) [11], Connective Tissue Growth Factor (CTGF) [12], Vascular
Endothelial Growth Factor (VEGF), Platelet Derivated Growth Factor
(PDGF) [5] and Transforming Growth Factor (TGF-b) [13]. In partic-
ular, TGF-b seems to play a key role in the formation of reactive
stroma, triggering phenotypic changes on cells that compose this
compartment. Under the inﬂuence of these factors, prostatic normal
stroma,whichwas originally composed of a large number of smooth
muscle cells, initially characterized by the expression of cytoskele-
ton proteins, such as desmin and calponin, becomes ﬁbrous with a
signiﬁcant increase in the number ofmyoﬁbroblasts [14]. Thismod-
iﬁed phenotype also induce stromal remodeling of the extracellular
matrix (ECM), which leads to the release of new growth factors and
ECM molecules, including type I and III collagens [15], tenascin-C,
versican, [16,17], and metalloproteinases 2 (MMP-2) and 9 (MMP-
9) [18], culminating with the formation of a reactive stroma.
Prostate reactive stroma formation is not an exclusive feature of
malignant neoplasic growth. Benign Prostatic Hyperplasia (BPH) is
characterized by benign prostatic tumor growth and occurs
concomitantly with cancer in more than 80% of cases [19,20]. Both
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cess [21], secretion of TGF-b and interleukin 8, further contributing
to the formation of a typical reactive stroma [22]. It has also been
reported that BPH reactive stroma contributes to LNCaP prostate
tumor cell formation in vivo, in a similar way as observed in PCa
[23]. In the present study, using a co-culture system and in vitro
functional assays, we investigated the role of different components
of BPH reactive stroma over LNCaP tumor cells. Tumor progression
features, such as cell proliferation, migration, apoptosis and the
expression of malignancy related genes were analyzed. Our data
indicated that ECM secreted by BPH reactive stroma was the most
prominent element to promote the major alterations and charac-
teristics associated with tumor progression.2. Materials and methods
2.1. Isolation and characterization of reactive stroma
Transurethral resection fragments of prostate tissues obtained from 3 BPH sur-
geries were used to obtain the BPH reactive stromal cells. This procedure was ap-
proved by the Ethics Committee of Clementino Fraga Filho University Hospital,
Federal University of Rio de Janeiro, and registered with the Protocol-CAAE
0029.0.197.000-05. Fragments of 1–3 mm3 were grown in 24-well plates containing
Dulbecco´s Modiﬁed Eagle´s Medium (DMEM) (Sigma) culture medium supple-
mented with 10% of Fetal Bovine Serum (FBS) (Hyclone), 100 units/mL penicillin
and 100 lg/mL streptomycin (Sigma). The medium was changed every 2 days. After
the cell attachment to the bottom of the culture plate, cells were trypsinized and
then transferred to 25 mm2 culture dishes. After six passages, a homogeneous stro-
mal cell population was established. To identify if these stromal cells presented a
reactive phenotype, these cells were immunocytochemically characterized for some
cytoskeleton markers. Cells were washed twice with PBS and ﬁxed with 4% parafor-
maldehyde-PBS (Sigma) for 10 min. After ﬁxation, they were washed for additional
three times with PBS and then incubated in a solution of 50 nM NH4Cl (Vetec) for
30 min. The antibody nonspeciﬁc binding was blocked with PBS/BSA 5% and then
primary antibodies were added over cell monolayers incubated overnight. We used
antibodies against vimentin (Sigma), a-smooth muscle actin (Sigma), cytokeratin
peptide 18 (Sigma) and desmin (Dako). To identify ECM components secreted by
these stromal cells, antibodies against ﬁbronectin (Sigma), laminin (Sigma), type I
and III collagens (Novotec), type IV collagen (Sigma) and chondroitin sulfate (Sig-
ma) were used. After incubation with primary antibodies, cells were washed with
PBS and incubated for 2 additional hours with either goat anti-mouse Alexa 488
or goat anti-rabbit Alexa 488/546 secondary antibodies (Invitrogen). Cell nuclei
were counterstained with DAPI (Santa Cruz Biotechnology). Finally, cells were
washed in distilled water and mounted on histological slides with N-propylgallate
(Sigma). Images were captured using a confocal microscopy (Olympus IX81) and a
Hamamatsu orcaR2 digital camera.
2.2. LNCaP cell culture
LNCaP cell linewas obtained from theAmerican Type Tissue Collection (Manassa,
VA) and maintained routinely in RPMI 1640 (Gibco) culture medium supplemented
with 10% FBS, 100 units/mL penicillin and 100 lg/mL streptomycin, except in control
or experimental conditions, in which FBS supplementation was theminimumneces-
sary for themaintenance of cell viability (0.5%), without interferingwith the analysis.
2.3. Experimental conditions
The experimental conditions used in all the assays were the following: (a)
LNCaP cells cultivated over the established reactive stromal cells, (b) LNCaP cells
cultivated in the presence of conditioned medium secreted by reactive stromal
cells, (c) LNCaP cells cultivated over the ECM secreted by reactive stromal cells
and (d) LNCaP cells cultivated in 0.5% FBS (control condition). For experimental con-
dition (a), reactive stromal cells were cultured in six well plates in complete med-
ium for 72 h. Then, culture medium was removed, cells were washed with balanced
saline solution (BSS) and incubated with 5 lM of the vital green ﬂuorescent dye
CMFDA (Molecular Probes) for 45 min. After this step, cells were washed and incu-
bated for 1 h in DMEM supplemented with 10% FBS before, being washed again
with BSS. After ﬂuorescent dye incorporation by the reactive stromal cells,
25  104 LNCaP cells were seeded over them and the new established co-culture
was maintained in DMEM with 0.5% FBS for a period of 72 h [7]. After this period,
LNCaP cells were separated from stromal cells by ﬂow cytometry (MoFlo, Dako
Cytomation), using an argon laser with a wavelength of 488 nm.
In order to obtain the conditioned medium and the ECM secreted by reactive
stromal cells mentioned on experimental conditions (b) and (c), respectively, we
employed protocols previously established [24]. Brieﬂy, 5  104 reactive stromal
cells were grown in 24-well plates with complete culture medium for 96 h. Then,medium was removed, cells were washed with BSS and maintained for more 24 h
in DMEM with 0.5% FBS. After this period, the supernatant (conditioned medium)
was collected, centrifuged (800 g) and ﬁnally added to 105 LNCaP cells that were
being cultured apart, and cultivated for 72 h. The ECM secreted by reactive stromal
cells was obtained culturing 5  104 stromal cells in 24-well plate with complete
medium for 96 h. After that, the medium was removed, cells were washed with
PBS supplemented with calcium chloride (PBS-Ca) and then 300 lL of lysis buffer
(PBS-Ca, 20 lM Leupeptin (Sigma), 1 mM PMSF (Sigma), 0.1% Triton X-100 (Sigma)
and 0.1 nM Ammonium Hydroxide (Vetec)) was added for 15 min and then washed
again tree times with PBS-Ca. This method removes the cells without disrupting the
cell matrix. Finally, 105 LNCaP cells were seeded and cultured over this secreted
matrix for 72 h. For experimental control condition (d), LNCaP cells were seeded
and cultured for 72 h in DMEM supplemented with 0.5% FBS.
2.4. Cell proliferation assays
In order to evaluate cell proliferation, crystal violet assay was employed. Cells
were ﬁxed in ethanol for 10 min, then stained with crystal violet 0.05% (Vetec)
for 10 min and ﬁnally solubilized with methanol. The supernatant was collected
and its absorbance was measured in an ELISA reader (BIO-RAD iMARKE) at
595 nm. Cell proliferation was also accessed by immunostaining LNCaP cells with
anti-histone H3p (Milipore) using the same protocol described above to character-
ize the reactive stromal cells. Cell cycle analysis was performed using propidium io-
dide assay. Brieﬂy, cells were resuspended in 500 lL of propidium iodide solution
(PBS, 0.1% Triton X-100, 0.1% RNAse and 50 lg/mL propidium iodide – Sigma)
and incubated for 5 min on ice. Cell cycle analysis was assessed by ﬂow cytometry
(FACScalibur BD Bioscience) after 20,000 events acquisition and the data were ana-
lyzed in Cell Quest software.
2.5. LNCaP apoptosis assays
LNCaP cells were resuspended in 400 lL of binding buffer containing 5 lL of
annexin V FITC and 5 lL propidium iodide (Apoptosis Detection Kit II BD
Biosciences) for 15 min at room temperature. Annexin V binding was evaluated
by ﬂow cytometry (FACScalibur BD Biosciences), after 20,000 events acquisition
and the data were analyzed in Cell Quest software.
2.6. LNCaP migration assays
LNCaP cell motility was characterized for each one of the experimental condi-
tions used so far. To do that, 1  105 LNCaP cells were plated and samples were
moved to a culture chamber, with controlled conditions of temperature and CO2
(37 C and 5%, respectively), adapted to an inverted microscope Nikon Eclipse TE
300 (Nikon). During 12 h, phase contrast images were captured every minute using
a Hamamatsu C2400 CCD camera (Hamamatsu, Japan). After the movie assembly,
10 different cells were marked with black dots 10 times smaller in diameter than
the cell at intervals of 10 min (72 images by movie), using the Image J software
(National Institutes of Health, USA). The labeled cell trajectories were obtained by
imaging analysis performed with the softwares Image J and Kaleidagraph (Synergy
Software, USA). From the trajectories, the tangencial velocity, (VT), and the spread-
ing velocity, (VS), were deﬁned (see Supplemental materials). The tangencial veloc-
ity is proportional to the total cell displacement in the period of 12 h and the
spreading velocity is proportional to the maximum cell displacement relating to
its initial position for the same time period.
2.7. Gene expression analysis
Total RNA from LNCaP cells was extracted using RNeasy Mini Kit (Qiagen)
according to the manufacture’s instructions. RNA yield and quality were deter-
mined by a spectrophotometer NanoDrop ND-1000 V3.2 (Nanodrop Technologies,
Inc., USA). Equal amounts (1 lg) of RNA from cells were reverse transcribed with
cDNA Syntesis kit ‘‘Superscript II First-Strand Synthesis System for RT-PCR’’
(Invitrogen) and Oligo (dT) primer (Invitrogen). The cDNA was used as a template
for subsequent real-time polymerase chain reaction (PCR). Quantitative real-time
PCR was done on a CFX96 Real Time System (BIORAD) C1000 Thermal Cycler using
SYBR Green (Applied Biosystems) following the manufacturer’s instructions. The
primers used for real-time PCR are listed in Supplementary Table 1. The expression
level of MMP2, MMP9, E-cadherin, N-cadherin, Vimentin, CdK1, CdK2, CK8, CK18,
Bax and Bcl-2 mRNA were all normalized with b-actin expression level. To evaluate
the quality of the real-time PCR products, melt curve analyses were performed after
each assay. Relative expression was determined using the DDCT method with
b-actin rRNA as the reference genes.
2.8. Statistical analysis
Statistical analysis was performed using the Graph Pad Prism 5.0 following by
Student t test, except in migration assay, where the nonparametric Kruskal–Wallis,
with Gaussian approximation in determining the assays values was used. Values
considered statistically signiﬁcant were those in which p < 0.05.
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3.1. Reactive stroma characterization
A homogeneous reactive stromal cell population derived from
BPH surgery resections was established. The primary cell culture
was characterized at each passage and it was observed a gradual
decrease in the number of rounded cells with epithelial appearance
and an increase in the number of elongated cells with ﬁbroblastic
aspects, as demonstrated by the phase contrast micrographs
(Fig. 1A and B). In previous studies it has been demonstrated that
prostate reactive stroma phenotype is characterized by an increase
in expression of cytoskeleton proteins, such as vimentin and
a-smooth muscle actin, followed by a decrease or absence of mus-
cle markers such as desmin [10,25]. We observed after six passages
in our culture system, a cell population positively staining for
vimentin (Fig. 1C and D) and a-smooth muscle actin (Fig. 1E and
F), but negative for cytokeratin 18 (Fig. 1G) and desmin (Fig. 1H).
These results indicated that a homogenous BPH stromal cell popu-
lation presenting a reactive phenotype was isolated. Moreover,
ECM secreted by these reactive stromal cells presented immuno-
staining for type I, III and IV collagens, laminin, ﬁbronectin and
chondroitin sulfate (Supplementary Fig. 2).3.2. Inﬂuence of reactive stroma on LNCaP cell morphology
Cell morphology analysis is an important tool that could pro-
vide relevant information about cell features or its microenviron-
ment [26]. LNCaP cells seeded in optimum culture condition (10%
of FBS supplementation) presented an elongated morphology, with
many cytoplasmic extensions (Supplementary Fig. 1A). However,
when LNCaP cells were cultivated in minimum medium (0.5%
FBS; control, Fig. 2A and B) or over reactive stromal cells (Fig. 2C
and D), they presented a more rounded shape, forming small clus-
ters. This morphological organization pattern was also similar to
that observed when LNCaP cells were cultured with the condi-
tioned medium secreted by reactive stromal cells (Fig. 2E and F).
Alternatively, when LNCaP cells were cultured over the ECM
produced by reactive stromal cells, they presented major cytoplas-
mic expansions, with a consequent increase in the number of cell
interconnections (Fig. 2G and H). These results are similar to that
observed when LNCaP cells were seeded in complete medium cul-
ture conditions indicating that ECM supports typical LNCaP cell
morphology, even in minimum serum supplementation.3.3. Soluble factors and ECM secreted by reactive stroma induce LNCaP
cell proliferation
Among numerous cellular events related to tumor progression,
one of them is the increase in cell proliferation. To address this, we
ﬁrst labeled reactive stromal cells with green CMFDA. Then, LNCaP
cells were layered over these labeled reactive stromal cells (Sup-
plementary Fig. 1). After 72 h, cell sorting efﬁciency of this model
was evaluated by ﬂow cytometry, thus allowing the segregation
of both cell populations with a high efﬁciency of 99.30% (Supple-
mentary Fig. 1B). Next, sorted LNCaP cells were evaluated for cell
proliferation by crystal violet assays 72 h after being co-cultured
over the reactive stromal cells (Fig. 3A). Our data demonstrated
that when co-cultured over reactive stromal cells, LNCaP cell pro-
liferation was not activated. However, when LNCaP cells were cul-
tured in the presence of conditioned medium secreted by reactive
stromal cells, there was a signiﬁcant increase in LNCaP cell prolif-
eration, as compared to control condition (p < 0.01 Fig. 3B).
Notably, the most pronounced effect over cell proliferation was
observed when LNCaP cells were cultured over ECM secreted bystromal cells, which induced an increase on growth rate
(p < 0.001 Fig. 3C). These data are all in agreement with the histone
H3p staining (Fig 3D) and the cell cycle analysis, in which the per-
centage of LNCaP cells at S and G2/M phases were increased when
these cells were cultured over the ECM secreted by the reactive
stroma, indicating that ECM activate LNCaP cell proliferation by
stimulating cell cycle entry (Fig. 3E and F).
3.4. Cell–cell and cell–ECM interactions modulate the survival of
LNCaP cells
The balance between cell proliferation and apoptotic cell death
is a well-established cancer imprint [27]. In order to understand
the inﬂuence of reactive stromal cells on LNCaP apoptotic cell
death, the proportion of positive annexin V+ LNCaP cells were eval-
uated under each experimental condition. LNCaP cells co-cultured
with reactive stromal cells presented a lower percent of apoptotic
cell death when compared to control situation (medium with min-
imal FBS) (Fig. 4A). The LNCaP cell apoptotic index was also lower
when these cells were seeded over the ECM secreted by reactive
stroma when compared with the control situation (Fig. 4C and
D). However, when LNCaP cells were cultured in the presence of
conditioned medium secreted by reactive stromal cells, the same
values of apoptotic cell death as that for the control was observed
(Fig 4B). Hence, these data indicate that reactive stromal cells and
its secreted ECM are both positively modulating the survival of
LNCaP cells.
3.5. LNCaP cell motility is modulated by the reactive stroma
The videomicroscopy assays employed to characterize the
LNCaP motility revealed that the interactions between the stroma
and its derived components with LNCaP cells produced different
responses. When compared to the control situation (Fig. 5A), the
spreading velocity was signiﬁcantly enhanced (p < 0.05) for each
tested situation. The highest increase in spreading velocity was ob-
served when LNCaP cells were plated over the ECM (p < 0.001 Fig
5A). The tangential velocity was also signiﬁcantly enhanced when
LNCaP cells were cultured over the ECM and stromal cells
(p < 0.001 Fig. 5B). No signiﬁcant differences were observed for
tangential velocity values for LNCap cells cultured in the presence
of conditioned medium when compared to the control situation
(Fig. 5B).
3.6. ECM secreted by reactive stroma induce a pro-tumorigenic gene
expression proﬁle
In order to delineate putative molecular mechanisms by which
secreted ECM is evoking LNCaP cell tumor progression features, we
then investigated gene expression proﬁling of several genes related
to PCa progression. LNCaP cells cultured over the ECM secreted by
reactive stroma promoted a signiﬁcant upregulation of MMP-2,
MMP-9, E-cadherin N-cadherin, vimentin, CDK1 and CDK2 genes,
while the expression pattern of CK8, CK18, Bcl-2 and BAX genes
was unaltered (Fig. 6). These data indicated that the effects of
secreted ECM on inducing LNCaP pro-tumorigenic features are
partially mediated by the net result of an upregulated expression
of several genes typically involved on PCa progression, such as
those that activate cell migration, invasion and epithelial-mesen-
chymal transition.4. Discussion
The fundamental role of tissue stroma on tumorigenesis and
tumor progression has been extensively investigated [2,3,27,28].
Fig. 1. Characterization of the stromal cell lineage. Phase-contrast micrographs of primary prostatic cells (A and B) and immunostaining for vimentin (C and D), a-smooth
muscle actin (E and F), cytokeratin 18 (G) and Desmin (H). Note the presence of cells with rounded conformation typically showed by epithelial-like cells in the ﬁrst passage
(A – arrow) and at the sixth passage a predominance of cells with typical mesenchymal appearance (B) and with a reactive phenotype (C–H) as showed by cytoskeleton
elements immunostaining.
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ment in response to tumor development is a common feature of
neoplastic tissues [26]. Under the nomenclature of reactive stroma,
the relevance of this compartment in PCa was reported by several
groups, demonstrating its role on modulating key events, such as
cell survival [9], proliferation [8] and angiogenesis [23]. A common
feature of most of these studies was the use of in vivo xenograft
models [7–9,12,23]. Apart from advantages of in vivo experimental
models, a notable disadvantage of these approaches corresponds to
difﬁculties to isolate the interacting variables. Therefore, we used
an in vitro system to investigate the contribution of the distinct
microenvironment stromal components on PCa progression,analyzing the role of cell–cell, cell–ECM and cell–soluble factors
interactions. In order to better understand the interactions medi-
ated by prostate reactive stroma, we established and characterized
herein a homogeneous population of stromal cells derived from
BPH presenting reactive phenotype. Our in vitro assays demon-
strated that secreted ECM signiﬁcantly induced LNCaP cell prolifer-
ation and migration, preserving its typical morphology, while
inhibiting apoptosis. On the other hand, reactive stromal cells per
se or their conditioned medium only partially modulated these
events. Furthermore, the use of BPH derived tissue in order to
obtain the reactive stroma in vitro, represents a reliable model to
assess how the interactions mediated by this compartment
Fig. 2. The LNCaP cell morphology is only supported by ECM. Phase-contrast micrographs (A, C, E, G), phalloidin staining (B, F, H) and immunostaining for cytokeratin 18 (D).
The morphology of LNCaP cells was evaluated 72 h after following culture conditions: Control (0.5% FBS) (B), upon the stromal cells (C and D), in the presence of stromal cells
conditioned medium (E and F) and over the ECM (G and H). The morphological aspects of LNCaP cells were observed only after cells were seeded over the ECM.
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lished reactive phenotype [22], besides being also validated in pre-
vious studies [14,23]. Among the interactions evaluated in our
study, those related to cell–ECM interactions represented the most
pronounced effects on positively modulating tumor events such as
proliferation, survival and migration.
Trying to identify molecules able to promote those effects of
ECM on LNCaP tumorigenic features we also investigated herein
which proteins are being expressed in the secreted ECM and also
the gene expression proﬁle this stromal component could induce
on LNCaP cells, enabling a pro-tumorigenic phenotype. By immu-
nocytochemistry analysis, we identiﬁed some ECM components
produced by reactive stromal cells (Supplementary Fig. 2A–F), suchas type I, III and IV collagens, laminin, ﬁbronectin and chondroitin
sulfate. Recent data has shown that increased cross-links between
collagen molecules activated growth and invasion of mammary tu-
mor cells [29]. Type I collagen is regarded as a natural barrier
against the invasion of tumor cells into the adjacent stroma,
although the increase in its synthesis is detected during the pro-
cess of metastasis [30]. It has been previously observed that in
PCa metastasis at bone tissues, the resident stromal cells decreased
type I, II, III and IV collagen synthesis [31]. However, the opposite
response was observed at early stages of tumor growth, like those
involving the reactive stroma generation. In this context, tumor
cells apparently induce collagen synthesis by prostate stromal cells
[10]. A prominent cancer ECMmolecule intensely studied has been
Fig. 3. LNCaP cells proliferation analysis. LNCaP cell proliferation was measured by colorimetric analysis of the incorporation of crystal violet 72 h after cultivation of LNCaP
cells upon the stromal cells (A), in the presence of conditioned medium (B) and upon the ECM (C). The conditioned medium and ECM induced the proliferation of LNCaP cells,
but the ECM did so more strongly and moreover the cells seeded over ECM showed a typical proﬁle of cells than are actively dividing with a pronounced percentage of cells at
S and G2/M phases as revealed by cell cycle (E and F). The dividing potential of LNCaP cells seeded upon ECM was conﬁrmed too by immunostaining for histone H3p (D). D
O = Optical Density; ⁄ = p < 0.05, ⁄⁄ = p < 0.01, ⁄⁄⁄ = p < 0.001.
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of laminin-5 becomes absent during progression of intraepithelial
neoplasia to PCa [32]. The downregulation of laminin-5 seems to
be related to the formation of a more passive microenvironment
to tumor growth, leading to changes in the expression of genes re-
lated to signaling, adhesion and cell cycle [33]. The cleavage of b-3
chain of laminin-5 matrix metalloproteinase by MT-1 generates a
80-kDa peptide responsible for the increased motility of prostate
tumor cell lines [34]. On the other hand, the study of DeOcampo
et al. [35], demonstrated that the interaction between laminin-1
and integrin a6b1 promotes phosphorylation of FAK (focal adhe-
sion kinase) and subsequent activation of MAP kinase, both cell
proliferation signaling pathways. In fact, these reports about the
relevance of laminin in the progression of PCa could explain some
of our results, in which we observed that when cultured over ECMsecreted by stromal cells, LNCaP cells were able to present a higher
proliferation rate, increased survival and migration capacities, fol-
lowed by positive modulation of genes involved with these events.
The gene expression pattern observed on LNCaP cells as a result
of secreted ECM interaction are in accordance to a model in which
stromal and PCa epithelial cells present close relationships, favoring
tumor progression. Stroma–epithelium interactions in the prostate
has been well documented and prostate stromal compartment has
demonstrated a pivotal role in PCa invasion andmetastasis [5], con-
ferring activation of cell growth and metastatic lesions of PCa cells
in an in vivo transplantation experiment [36]. It is also well known
that some stromal factors further induce epithelial cells to produce
several gene products related to tumor progression [37,38]. Some of
these molecules are importantly involved on ECM remodeling [36]
and epithelial-mesenchymal plasticity [39]. We observed herein
Fig. 4. LNCaP annexin V apoptosis assay. Representative Histograms relating the ﬂuorescence emission for Annexin-V in LNCaP cells cultured for 72 h upon the stromal cells
(A) in the presence of conditioned medium (B) and upon the ECM (C). Percentage of Annexin-V+ cells(D).
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upregulated when LNCaP cells were cultured over ECM secreted
by stromal cells, and possibly being involved on favoring LNCaP
pro-tumorigenic features. The proteolytic degradation of ECMmed-
iated by extracellular proteases, such as MMPs, is required for PCa
cell migration and invasion. Among them,MMP-2 andMMP-9 pres-
ent critical roles in PCa progression, by presenting proteolytic activ-
ity against a variety of ECM substrates, including collagens,
proteoglycans, elastin, laminin, ﬁbronectin, and casein [40].We also
found that secreted ECM positively modulates the expression of
several epithelial-mesenchymal (EMT) and mesenchymal-epithe-
lial (MET) transition markers, also more recently described as pro-
teins conferring phenotypic plasticity. These phenotypic changes
has been interpreted as the ability to easily transit between epithe-
lial-like and mesenchymal-like states. These transitions have beendiscussed as being linked to stem cell–like properties and as more
important determinants of aggressive metastatic behavior than
the properties of the end states. It has been reported thatmetastatic
PCa cells co-express epithelial and mesenchimal markers, such
E-cadherin, N-cadherin, vimentin and cytokeratins, indicating phe-
notypic plasticity in these cells [41]. Our data presented similar re-
sults on cell cultured upon secreted ECM. Although it has been
demonstrated that in human PCa occurs loss of E-cadherin expres-
sion and overexpression of N-cadherin, indicating EMT and metas-
tasis activation [41], other authors have described that in PCa,
attachment of metastatic cells to bone cells correlates with overex-
pression of E-cadherin [42] and that exit from EMT is marked by
increased E-cadherin expression, which has been considered neces-
sary for tumor growth at sites of metastasis [43]. CDK1 and CDK2,
which function at different stages of the mammalian cell cycle,
Fig. 5. Cell migration analysis by videomicroscopy. LNCaP cells spreading velocity
(A) and tangential velocity (B). LNCaP spreading velocity rate was higher when
these cells were seeded upon the ECM and tangential velocity was more
pronounced over the stromal cells. NS = no signiﬁcance.
Fig. 6. Gene expression proﬁle in EMC. Quantitative real-time PCR analysis of
different genes studied in ECM, after 72 h of incubation. Gene expression is
presented as fold expression compared with LNCaP cells cultivated in 0.5% FBS
(control condition). MMP2, MMP9, E-cadherin, Vimentin, CdK1 and CdK2 gene
expression were signiﬁcantly increased in ECM compared with control cells. b-actin
RNA transcript levels were used for the internal control. The values are expressed as
means ± S.D. (n = 4), and the P-values were <0.05 (⁄) and <0.01 (⁄⁄). MMP, matrix
metalloproteinase; CdK, Cyclin dependent kinase; CK, cytokeratin; Bax, Bcl-2-
associated X protein; BCl, B-cell lymphoma.
62 A. Palumbo Jr. et al. / Cancer Letters 321 (2012) 55–64has also been reported as presenting important roles on PCa cell
proliferation and survival [44] also were upregulated as a result of
LNCaP cultured upon ECM. Although Bax and Bcl-2 transcripts did
no presented upregulated expression on LNCaP cell cultured over
secreted ECM, it is possible that other apoptosis regulatory targets
are mainly controlling the pro-survival role of this stromal
compartment.
Our results showed a signiﬁcant increase in survival, but not in
the proliferative activity of LNCaP cells, when they were co-cul-
tured over the reactive stromal cells. In fact, data from Olumiet al. [7] demonstrated that the formation of tumors in nude mice
by LNCaP cells occurred primarily by a decrease in apoptosis of
these tumor cells under the inﬂuence of stromal cells. Moreover,
the morphology of LNCaP cells in contact with reactive stromal
cells was quite different from the elongated morphology, as com-
pared to optimum culture conditions (Supplementary Fig. 1A). This
observation may partially explain the absence of LNCaP cells prolif-
eration when in co-culture, since cells derived from solid tumors
require a proper grounding in order to proliferate [26]. Therefore,
whenever these cells do not appear to be ﬁrmly anchored, the sig-
naling dependent on this interaction will not occur and the prolif-
eration will be inhibited. One potential target for future studies
may reside in the protein N-cadherin, which can be expressed by
both tumor and stromal cells [24]. A possible down-regulation of
this protein in reactive stromal cells might reduce the interaction
of this compartment with tumor cells, thereby altering adhesion
between both populations as observed in our data. On the other
hand, the in vitro apparently lack of interactions between different
cell populations could just reﬂect a well known behavior of tumor
cells in vivo, which is the lack of adherence and the consequent in-
crease in cell migration associated with metastasis [26]. The in-
creased survival of LNCaP cells when co-cultured over reactive
stromal cells may be related to other adhesion proteins such as
cadherins and integrins that can interact to each other, forming
heterotypic connections able to activate signaling pathways such
as AKT, which are responsible for cell survival [45]. Analysis of cell
migration by videomicroscopy revealed the absence of cytoplasmic
expansions of LNCaP cells when cultured upon the stromal cells,
which could be related with the lack of structures necessary for cell
migration as lamellipodia, ﬁlopodia and invadopodia [46]. More-
over, when cultured over the reactive stromal ECM, LNCaP cells
presented a directed movement (higher values of spreading veloc-
ity VS, Fig. 5A). This kind of movement may be a consequence of an
eventual protein trail that was left in the coverslip after reactive
stromal cell lysis. LNCaP cells possibly adhered preferentially over
proteins in this trail. By evaluating LNCaP cell tangential velocity VT
(Fig. 5B), we demonstrated that when co-cultured with reactive
stromal cells or cultivated over reactive stromal ECM, the cell
machinery is activated to move faster, so that, the cell motility is
increased in those situations. The reactive stromal cells may be sig-
naling to LNCaP cells, increasing their motility. The biggest values
of VT were found when LNCaP cells were co-cultured with the reac-
tive stromal cells. In this situation, there is also a contribution of
LNCaP tangential velocity due to reactive stromal cell movement.
Aiming to verify the inﬂuence of the stromal cell displacement,
images of stromal cell culture were captured following the same
procedure described at the motility assays (see Section 2). Stromal
cells were attached to uncoated polystyerene spheres of diameter
3 lm, mimicking LNCap cells. In this situation, it was not observed
signiﬁcant differences for the tangential velocity values when com-
pared to control (data not shown). These results indicated that
reactive stromal cell proteins or soluble factors released by these
stromal cells increase LNCaP motility activating the proteins and
signaling involved with this process. LNCaP cells cultured in the
presence of conditioned medium produced by reactive stromal
cells presented a signiﬁcant increase on proliferation level. Regard-
ing apoptosis index and migration behaviors, no difference has
been observed as compared to control condition. Increased prolif-
eration when LNCaP cells were cultured in conditioned medium
secreted by reactive stromal cells may be a result of the inﬂuence
of several growth factors. Among them, b-FGF was highlighted as
the most potent mitogen among those mapped by Gleave in condi-
tioned medium secreted by prostate ﬁbroblasts, being also capable
of inducing tumor formation in nude mice [47]. In PCa tumors,
FGF-2 is upregulated in stroma compartment, as compared to epi-
thelial ones [48] and is able to stimulate the proliferation and
A. Palumbo Jr. et al. / Cancer Letters 321 (2012) 55–64 63secretion of proteases related to metastasis [10]. TGF-b seems to be
used by tumor cells, since they decrease the expression of TGF-b
receptors and increase the binder production which will operate
in the adjacent stroma promoting the generation of reactive stro-
ma that ultimately promotes tumor growth. Our results apparently
demonstrated that classical anti-proliferative signaling pathway
mediated by TGF-b is not happening, since there was no prolifera-
tion inhibition of LNCaP cells when cultured in the presence of the
conditioned medium. A reasonable explanation could reside in the
TGF-b ability to induce the expression of receptors for growth fac-
tor-derived stroma (SDF) CXCR4, which then activate the AKT
pathway, thus contributing to tumor growth as observed by Mingf-
ang et al. [25]. A large amount of IL-6, another important cancer-
related cytokine, has been detected in conditioned medium pro-
duced by BPH stromal cells. It has also been demonstrated it was
able to induce tumor cell apoptosis [49]. These reports could ex-
plain part of our results, since in our data it has not been observed
a signiﬁcant survival difference for LNCaP cells cultured in the
presence of conditioned medium, as compared to control condi-
tion. Moreover, the altered morphology and low motility of LNCaP
cells cultured in the presence of conditioned medium could be also
related with IL-6 as previously showed [50].5. Conclusions
This in vitro study contributes to a better understanding of the
roles of reactive stromal compartment over PCa progression fea-
tures. The interactions between this compartment and tumor cells
can generate antagonistic responses mediated by direct contact
with reactive stromal cells or their secreted soluble factors. In con-
trast, the signaling mediated by the extracellular matrix secreted
by the reactive stroma activates the malignant phenotype of tumor
cells used in our study. These data could reﬂect the existence of
some heterogeneous biological responses in the stromal microen-
vironment that positively or negatively control some key stages
of PCa progression. Finally, we propose that the ECM produced
by reactive stroma contain key molecules mediating part of tumor
microenvironment effects over prostate tumor progression, by
activating the expression of target genes involved in these
processes.
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